Desentum Competitors and Similar CompaniesClear all

Desentum's competitors and similar companies include Allergopharma, Allergon and UCB.

	Desentum Desentum is a biopharmaceutical company developing allergen immunotherapy products (allergy vaccines).	Allergopharma Allergopharma is a company engaged in the field of allergen immunotherapy (AIT).	Allergon Allergon is a company producing a variety of allergen source materials, including moulds, mites, epithelia, and food allergens.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 2011	Founding Date 1969	Founding Date 1963	Founding Date 1928
Type	Type Private	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Manufacturing & Industrial biotech genetics pharma	Tags Manufacturing & Industrial biotech genetics therapy	Tags Healthcare biotech drug development pharma
Locations	Locations Espoo, FI HQ Helsinki, FI	Locations Reinbek, DE HQ Wien, AT Reinbek, DE Przyszowice, PL Madrid, ES Hünenberg, CH Istanbul, TR	Locations Ängelholm, SE HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 1110% increase	Employees 2051% increase	Employees 254% decrease	Employees 9,052
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr130.6m (FY, 2021)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods kr88.7m (FY, 2021)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit kr41.8m (FY, 2021)	Gross profit €7.2b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income kr3.5m (FY, 2021)	Net income €1.6b (FY, 2025)
Operating ⚠
Trademarks	Trademarks N/A	Trademarks 87 (Nov, 2022)	Trademarks 6 (Nov, 2022)	Trademarks N/A